v3.26.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (1,300,362) $ (832,894)
Adjustments to reconcile net loss to net cash used in operating activities:    
Common stock issued for services 156,706 196,550
Depreciation and amortization 180,977
Stock-based compensation expense 419,240
Change in fair value of other current liabilities (137,840)
Change in fair value of convertible notes payable (163,888)
Foreign currency translation adjustment reclassified to earnings 8,621
Amortization of debt discount 14,355 1,826
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (8,034) 35,994
Other assets 15,516
Deferred revenue 57,974
Accounts payable and accrued expenses 91,369 70,388
Net cash used in operating activities (680,882) (512,620)
Cash flows from investing activities    
Advances to suppliers for software (40,000)
Payments for capitalized software (26,750)
Net cash used in investing activities (26,750) (40,000)
Cash flows from financing activities    
Issuance of common stock 23,500
Issuance of common stock with warrants 105,000
Issuance of notes payable 21,000 115,000
Repayment of notes payable (637)
Issuance of notes payable with common stock 40,000
Issuance of convertible notes payable with common stock 25,000
Issuance of convertible notes payable 117,000
Repayment of convertible notes payable (70,000)
Payment of deferred offering costs (1,600)
Net cash provided by financing activities 154,263 220,000
Effect of exchange rate changes on cash (523)
Net decrease in cash (553,369) (333,143)
Cash as of beginning of year 573,305 928,619
Cash as of end of year 19,936 595,476
Supplemental disclosure of cash flow information    
Cash paid for interest 1,063
Supplemental disclosure of non-cash investing and financing activity    
Amount payable for capitalized software 4,500
Convertible notes payable converted into equity 163,841
Other current liabilities satisfied with issuance of common stock 613,800
Accrued deferred offering costs 15,907
Warrants issued with notes payable $ 29,260